1 / 6

Canada: Challenges and Models for Biotechnological Innovation.

Canada: Challenges and Models for Biotechnological Innovation. Tania M. Bubela, BSc, PhD, LLB School of Business, University of Alberta and the Centre for Intellectual Property Policy, McGill University

adelio
Télécharger la présentation

Canada: Challenges and Models for Biotechnological Innovation.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Canada: Challenges and Models for Biotechnological Innovation. Tania M. Bubela, BSc, PhD, LLB School of Business, University of Alberta and the Centre for Intellectual Property Policy, McGill University Workshop on Intellectual Property, Biotechnology Capacity and Development, September 25-27, 2006

  2. Problems • Canada is lagging behind other countries in innovative development (OECD) • Federalism: Split jurisdiction for Science and Technology • Retention and Attraction of Highly Qualified Personnel (HQPs) • Lack of Venture Capital

  3. Approaches • Models to enhance research collaboration and knowledge mobilization • Networks of Centres of Excellence (NCEs) • Genome Canada • Model to enhance scientific infrastructure • Canadian Foundation for Innovation • Model to enhance retention & recruitment • Canada Research Chairs

  4. Approaches • Models to Enhance Venture Capital • Genome Canada • Institutional Initiatives (technology parks, incubation facilities e.g., MaRS) • Provincial Initiatives (VRQ)

  5. Lessons Learned • NCE and Genome Canada models • Need better management of IP strategies • Lack of inter-institutional coordination • Need vision of purpose of commercialization strategies around IP (licensing vs spin-offs vs knowledge mobilization) • Need better metrics

  6. Conclusions from CIPP study • Create Canadian forum to address tech and knowledge transfer issues • Develop a Canada-wide technology and knowledge transfer strategy, including model agreements • Investigate ways to bridge funding gap • Increase capacity in IP and tech and knowledge transfer

More Related